PRTA
NASDAQ · Biotechnology
Prothena Corp Plc
$8.93
+0.44 (+5.18%)
Open$8.63
Previous Close$8.49
Day High$9.15
Day Low$8.52
52W High$11.80
52W Low$5.64
Volume—
Avg Volume601.2K
Market Cap467.51M
P/E Ratio—
EPS$-2.81
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+51.4% upside
Current
$8.93
$8.93
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.19M | 18.07M | 162.70M |
| Net Income | -256,968,598 | -409,838,274 | -26,550,677 |
| Profit Margin | -2,520.6% | -2,394.5% | -16.3% |
| EBITDA | -225,018,945 | -378,819,772 | -39,466,979 |
| Free Cash Flow | — | — | -19,760,246 |
| Rev Growth | -43.6% | -43.6% | +13.5% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |